PALB2 and urinary bladder carcinoma: Among bladder cancer cases the PALB2 mutations (two variants combined) were found in 0.35% of the patients and in 0.21% of the controls (OR = 1.7; 95% CI 0.56–4.88; p = 0.52) (Table 1).